A database of FDA approved therapeutic peptides and proteins
ID | ThPPID | Name | Peptide Sequence | Length | Functional Classification | Disease | Brand | Company | Physical Appearance | Route of Administartion | Category | Target |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1331 | Th1047 | Alpha-1-proteinase inhibitor | EDPQGDAAQKTDTSHHDQDH Full view | 255 | IIa | Metabolic/Geneti/Respiratory | Aralast | Baxter | Lyophilized powder | Intravenous infusion | Serine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | Neutrophil elastase |
1332 | Th1047 | Alpha-1-proteinase inhibitor | EDPQGDAAQKTDTSHHDQDH Full view | 255 | IIa | Metabolic/Geneti/Respiratory | Prolastin | Talecris Biotherapeutics C formerly Bayer | Lyophilized powder | Intravenous infusion | Serine Proteinase Inhibitors, Enzyme replacement agents, trypsin inhibitors | Neutrophil elastase |
1706 | Th1169 | Beractant | NA Full view | 0 | Ia | Respiratory | Survanta | Abb Vie Inc. | Suspension | Endotracheal | NA | NA |
1707 | Th1169 | Beractant | NA Full view | 0 | Ia | Respiratory Disorder | Survanta | Abbvie Corporation | Suspension | Intratracheal | NA | NA |
1810 | Th1201 | Poractant alfa | NA Full view | 0 | Ia | Respiratory Disorder | Curosurf | Chiesi USA, Inc | Suspension | Endotracheal | Pulmonary Surfactants | |
1819 | Th1210 | Mepolizumab | NA Full view | 0 | Ib | Respiratory Disorder | Nucala | Glaxosmithkline Inc | Lyophilized Powder | Subcutaneous | Antineoplastic and Immunomodulating Agents, Immunosuppressive Agents, Interleukin Inhibitors | Interleukin-5 |